IM Cannabis (IMCC) EBITDA Margin (2020 - 2026)

IM Cannabis' EBITDA Margin history runs 7 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, EBITDA Margin rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 10.26% (down 2421.0% YoY), while the FY2025 annual figure was 21.17%, down 2116.0% from the prior year.
• EBITDA Margin was 0.01% for Q1 2026 at IM Cannabis, up from 49.11% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 899.17% in Q3 2022 to a low of 234.41% in Q4 2022.
• Historically, EBITDA Margin has averaged 41.53% across 5 years, with a median of 0.04% in 2024.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin surged 95811 bps in 2022, then plunged 91484 bps in 2023.
• A 5-year view of EBITDA Margin shows it stood at 234.41% in 2022, then jumped by 117 bps to 39.1% in 2023, then jumped by 81 bps to 70.68% in 2024, then plunged by 169 bps to 49.11% in 2025, then surged by 100 bps to 0.01% in 2026.
• The last three EBITDA Margin figures came in at 0.01% (Q1 2026), 49.11% (Q4 2025), and 27.9% (Q3 2025), per Business Quant data.